Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 6 August 1982:
Vol. 217. no. 4559, pp. 540 - 542
DOI: 10.1126/science.7046053

Articles

Science, Vol 217, Issue 4559, 540-542
Copyright © 1982 by American Association for the Advancement of Science


articles

Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin

KV Honn, P Cavanaugh, C Evens, JD Taylor, and BF Sloane

The ability of tumor cells to metastasize may be related to their ability to promote aggregation of host platelets. The use of inhibitors of cysteine proteinases resulted in parallel inhibition of B16 amelanotic melanoma-induced platelet aggregation and of a cathepsin B activity. The antimetastatic agent prostacyclin inhibited platelet aggregation induced by the tumor cells and by papain, a cathepsin B-mimicking agent.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of Metastases by Anticoagulants.
M. Hejna, M. Raderer, and C. C. Zielinski (1999)
J Natl Cancer Inst 91, 22-36
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)